J. Lipid Res. Neurobiology of Lipids (ISSN1683-5506)
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Originally published In Press as doi:10.1194/jlr.M600005-JLR200 on April 25, 2006

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
M600005-JLR200v1
47/7/1366    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Castellani, L. W.
Right arrow Articles by Reynolds, W. F.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Castellani, L. W.
Right arrow Articles by Reynolds, W. F.
Social Bookmarking
Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Journal of Lipid Research, Vol. 47, 1366-1377, July 2006
Copyright © 2006 by American Society for Biochemistry and Molecular Biology

Transgenic mice express human MPO –463G/A alleles at atherosclerotic lesions, developing hyperlipidemia and obesity in –463G males

Lawrence W. Castellani*, James J. Chang{dagger}, Xuping Wang*, Aldons J. Lusis* and Wanda F. Reynolds1,{dagger}

* Departments of Medicine, Microbiology, and Molecular Genetics, University of California-Los Angeles, Los Angeles, CA 90095
{dagger} Sidney Kimmel Cancer Center, San Diego, CA 92121

Published, JLR Papers in Press, April 25, 2006.

1 To whom correspondence should be addressed. e-mail: wreynolds{at}skcc.org

Myeloperoxidase (MPO) is an oxidant-generating enzyme present in macrophages at atherosclerotic lesions and implicated in coronary artery disease (CAD). Although mouse models are important for investigating the role of MPO in atherosclerosis, neither mouse MPO nor its oxidation products are detected in lesions in murine models. To circumvent this problem, we generated transgenic mice expressing two functionally different human MPO alleles, with either G or A at position –463, and crossed these to the LDL receptor-deficient (LDLR–/–) mouse. The –463G allele is linked to higher MPO expression and increased CAD incidence in humans. Both MPO alleles were expressed in a subset of lesions in high-fat-fed LDLR–/– mice, notably at necrotic lesions with cholesterol clefts. MPOG-expressing LDLR–/– males (but not females) developed significantly higher serum cholesterol, triglycerides, and glucose, all correlating with increased weight gain/obesity, implicating MPO in lipid homeostasis. The MPOG- and MPOA-expressing LDLR–/– males also exhibited significantly larger aortic lesions than control LDLR–/– males. The human MPO transgenic model will facilitate studies of MPO involvement in atherosclerosis and lipid homeostasis.

Supplementary key words myeloperoxidase • atherosclerosis • hyperlipidemia • cholesterol • triglycerides • macrophage


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 All ASBMB Journals   Journal of Biological Chemistry 
 Molecular and Cellular Proteomics   ASBMB Today 
Copyright © 2006 by the American Society for Biochemistry and Molecular Biology.